| abstract |
The present invention provides a nucleic acid molecule that can bind to c-Met as a substance that can be used for elucidation, diagnosis, treatment, and the like of the onset mechanism of diseases caused by c-Met, and uses thereof. The c-Met binding nucleic acid molecule of the present invention is any one of the following (A1), (A2), (B1) and (B2) nucleic acid molecules. (A1) Nucleic acid molecule comprising the base sequence represented by any of SEQ ID NOs: 1 to 38 (A2) In the base sequence represented by any of SEQ ID NOs: 1 to 38, one or more bases are substituted, deleted, Nucleic acid molecule (B2) comprising any nucleotide sequence represented by any of SEQ ID NOs: 39 to 76, which includes an added or inserted nucleotide sequence and is capable of binding to c-Met A nucleic acid molecule comprising one or a plurality of base sequences substituted, deleted, added or inserted and capable of binding to c-Met |